Bio-Techne Corporation Revenue 2009–2025
Bio-Techne Corporation reported $1.22B of revenue for fiscal 2025. That was 5.2% higher than fiscal 2024. Compared with fiscal 2020, the change was +65.1%.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $1.22B | +5.2% |
| FY 2024 | $1.16B | +2.0% |
| FY 2023 | $1.14B | +2.8% |
| FY 2022 | $1.11B | +18.7% |
| FY 2021 | $931.03M | +26.0% |
| FY 2020 | $738.69M | +3.5% |
| FY 2019 | $714.01M | +11.0% |
| FY 2018 | $642.99M | +14.2% |
| FY 2017 | $563.00M | +12.8% |
| FY 2016 | $499.02M | +10.3% |
| FY 2015 | $452.25M | +26.4% |
| FY 2014 | $357.76M | +15.2% |
| FY 2013 | $310.57M | -1.3% |
| FY 2012 | $314.56M | +8.5% |
| FY 2011 | $289.96M | +7.8% |
| FY 2010 | $269.05M | +1.9% |
| FY 2009 | $263.96M | — |
Source: Bio-Techne Corporation SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open TECH 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Bio-Techne Corporation reported $1.22B of revenue for fiscal 2025. That was 5.2% higher than fiscal 2024. Compared with fiscal 2020, the change was +65.1%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Bio-Techne Corporation
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeBio-Techne Corporation — frequently asked questions
What is Bio-Techne Corporation's revenue?
Bio-Techne Corporation (TECH) reported revenue of $1.22B for fiscal year 2025, per its SEC filings.
How has Bio-Techne Corporation's revenue changed over time?
Between fiscal 2009 and 2025, TECH's revenue grew at roughly 10.0% per year (compound annual rate), from $263.96M to $1.22B.
Where does this data come from?
Figures are computed from Bio-Techne Corporation's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.